Kestra Private Wealth Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Buy |
35,130
+5,534
| +19% | +$614K | 0.06% | 326 |
|
|
2025
Q1 | $3.32M | Buy |
29,596
+228
| +0.8% | +$25.5K | 0.06% | 339 |
|
|
2024
Q4 | $2.71M | Buy |
29,368
+1,247
| +4% | +$115K | 0.05% | 359 |
|
|
2024
Q3 | $2.36M | Sell |
28,121
-6,876
| -20% | -$576K | 0.04% | 386 |
|
|
2024
Q2 | $2.4M | Sell |
34,997
-7,202
| -17% | -$494K | 0.05% | 351 |
|
|
2024
Q1 | $3.09M | Sell |
42,199
-4,446
| -10% | -$326K | 0.07% | 280 |
|
|
2023
Q4 | $3.78M | Buy |
46,645
+7,257
| +18% | +$588K | 0.1% | 224 |
|
|
2023
Q3 | $2.95M | Buy |
39,388
+1,319
| +3% | +$98.8K | 0.09% | 239 |
|
|
2023
Q2 | $2.93M | Buy |
38,069
+2,606
| +7% | +$201K | 0.1% | 220 |
|
|
2023
Q1 | $2.94M | Buy |
35,463
+12,129
| +52% | +$1.01M | 0.12% | 192 |
|
|
2022
Q4 | $2M | Sell |
23,334
-2,097
| -8% | -$180K | 0.1% | 229 |
|
|
2022
Q3 | $1.57M | Sell |
25,431
-3,711
| -13% | -$229K | 0.09% | 253 |
|
|
2022
Q2 | $1.8M | Sell |
29,142
-2,730
| -9% | -$169K | 0.1% | 238 |
|
|
2022
Q1 | $1.9M | Buy |
31,872
+4,816
| +18% | +$286K | 0.09% | 231 |
|
|
2021
Q4 | $1.97M | Sell |
27,056
-13,479
| -33% | -$979K | 0.09% | 228 |
|
|
2021
Q3 | $2.83M | Buy |
40,535
+2,483
| +7% | +$173K | 0.16% | 150 |
|
|
2021
Q2 | $2.62M | Buy |
38,052
+1,235
| +3% | +$85K | 0.16% | 145 |
|
|
2021
Q1 | $2.38M | Sell |
36,817
-1,454
| -4% | -$94K | 0.17% | 149 |
|
|
2020
Q4 | $2.17M | Buy |
38,271
+15,917
| +71% | +$902K | 0.16% | 149 |
|
|
2020
Q3 | $1.44M | Buy |
+22,354
| New | +$1.44M | 0.12% | 181 |
|